Eisler Capital (Uk) Ltd. Zoetis Inc. Call Options Transaction History

Eisler Capital (Uk) Ltd.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$172.58 - $196.48 $59,712 - $67,982	346 Added 1.74%	20,227 $3.95 Million
Q2 2024 Aug 13, 2024	SELL	$145.54 - $178.83 $707,615 - $869,471	-4,862 Reduced 19.65%	19,881 $3.45 Million
Q1 2024 May 14, 2024	BUY	$165.67 - $199.94 $1.42 Million - $1.71 Million	8,558 Added 52.88%	24,743 $4.19 Million
Q4 2023 Feb 13, 2024	BUY	$151.44 - $200.09 $1.8 Million - $2.38 Million	11,914 Added 278.95%	16,185 $3.19 Million
Q3 2023 Nov 13, 2023	BUY	$167.14 - $192.77 $713,854 - $823,320	4,271 New	4,271 $743,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.